RE: CholBiomeX3 is £23 a box8 Oct 2020 00:41
The risk of waiting to see hard cold cash on the balance sheet before investing is that ,if it happens, the SP will be then much higher than it is now .We operate with remarkably low overheads,have issued very few shares,will sell a few more Skbt should we need a modest fundraise, & if we can generate substantially increased revenues (increasingly likely) our net profits & cashflow will rapidly increase thereby justifying our current valuation & supporting a relate to a much higher level.Still high risk but much less than when our SP was double its current level,in the not too distant past .